Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

GLPG

Galapagos NV (GLPG)

Galapagos NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GLPG
DateTimeSourceHeadlineSymbolCompany
17/05/202406:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
17/05/202406:01GlobeNewswire Inc.Galapagos creates new subscription right plansNASDAQ:GLPGGalapagos NV
16/05/202422:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
16/05/202406:01GlobeNewswire Inc.Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.NASDAQ:GLPGGalapagos NV
03/05/202406:01GlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  NASDAQ:GLPGGalapagos NV
01/05/202406:01GlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024NASDAQ:GLPGGalapagos NV
05/04/202407:01GlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024NASDAQ:GLPGGalapagos NV
29/03/202407:01GlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsNASDAQ:GLPGGalapagos NV
27/03/202407:01GlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardNASDAQ:GLPGGalapagos NV
23/02/202422:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
23/02/202408:01GlobeNewswire Inc.Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage PipelineNASDAQ:GLPGGalapagos NV
23/02/202408:01GlobeNewswire Inc.Galapagos announces full year 2023 results and outlook for 2024NASDAQ:GLPGGalapagos NV
16/02/202422:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
16/02/202408:01GlobeNewswire Inc.Galapagos presents at EBMT-EHA annual meeting 2024NASDAQ:GLPGGalapagos NV
15/02/202409:41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GLPGGalapagos NV
01/02/202408:01GlobeNewswire Inc.Galapagos completes transaction to transfer Jyseleca® business to AlfasigmaNASDAQ:GLPGGalapagos NV
05/01/202408:44Dow Jones NewsGalapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer DrugNASDAQ:GLPGGalapagos NV
05/01/202408:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
05/01/202408:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
05/01/202408:01GlobeNewswire Inc.Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.NASDAQ:GLPGGalapagos NV
04/01/202408:01GlobeNewswire Inc.Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncologyNASDAQ:GLPGGalapagos NV
04/01/202408:01PR Newswire (US)BridGene Biosciences Announces Strategic Collaboration with Galapagos to Discover Small Molecule Drugs for Oncology TargetsNASDAQ:GLPGGalapagos NV
02/01/202417:00GlobeNewswire Inc.Galapagos signs agreement to transfer Jyseleca® business to AlfasigmaNASDAQ:GLPGGalapagos NV
22/12/202308:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
20/12/202308:01GlobeNewswire Inc.Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301NASDAQ:GLPGGalapagos NV
10/12/202304:00GlobeNewswire Inc.Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101NASDAQ:GLPGGalapagos NV
08/12/202308:01GlobeNewswire Inc.Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023NASDAQ:GLPGGalapagos NV
06/11/202323:45PR Newswire (US)Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-CareNASDAQ:GLPGGalapagos NV
03/11/202323:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GLPGGalapagos NV
03/11/202307:01GlobeNewswire Inc.Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023NASDAQ:GLPGGalapagos NV
 Showing the most relevant articles for your search:NASDAQ:GLPG